Novartis AG banner

Novartis AG
XHAM:NOT

Watchlist Manager
Novartis AG Logo
Novartis AG
XHAM:NOT
Watchlist
Price: 80.19 EUR Market Closed
Market Cap: €179.4B

Wall St Price Targets

NOT Price Targets Summary
Novartis AG

Wall Street analysts forecast NOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOT is 136.81 EUR with a low forecast of 104 EUR and a high forecast of 163.33 EUR.

Lowest Forecast
Price Target
104 EUR
30% Upside
Average Forecast
Price Target
136.81 EUR
71% Upside
Highest Forecast
Price Target
163.33 EUR
104% Upside
Novartis AG Competitors:
Price Targets

Revenue
Forecast

0% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
0% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.

Gross Profit
Forecast

1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Novartis AG

Operating Income
Forecast

4% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss
4% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 4%.

Pre-Tax Income
Forecast

3% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
3% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Novartis AG

Net Income
Forecast

3% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
3% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 5%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NOT's stock price target?
Price Target
136.81 EUR

According to Wall Street analysts, the average 1-year price target for NOT is 136.81 EUR with a low forecast of 104 EUR and a high forecast of 163.33 EUR.

What is the Revenue forecast for Novartis AG?
Projected CAGR
2%

Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.

What is the Operating Income forecast for Novartis AG?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 4%.

What is the Net Income forecast for Novartis AG?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 5%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett